A PharmaVoice report published on May 13, 2026 by Kelly Bilodeau examines how India’s pharmaceutical industry is expanding globally through major acquisitions such as Sun Pharma’s $11.75 billion Organon deal. The article highlights growing ambition to compete with global leaders,
